Literature DB >> 22698286

The vertebrate mitotic checkpoint protein BUBR1 is an unusual pseudokinase.

Saskia J E Suijkerbuijk1, Teunis J P van Dam, G Elif Karagöz, Eleonore von Castelmur, Nina C Hubner, Afonso M S Duarte, Mathijs Vleugel, Anastassis Perrakis, Stefan G D Rüdiger, Berend Snel, Geert J P L Kops.   

Abstract

Chromosomal stability is safeguarded by a mitotic checkpoint, of which BUB1 and Mad3/BUBR1 are core components. These paralogs have similar, but not identical, domain organization. We show that Mad3/BUBR1 and BUB1 paralogous pairs arose by nine independent gene duplications throughout evolution, followed by parallel subfunctionalization in which preservation of the ancestral, amino-terminal KEN box or kinase domain was mutually exclusive. In one exception, vertebrate BUBR1-defined by the KEN box-preserved the kinase domain but allowed nonconserved degeneration of catalytic motifs. Although BUBR1 evolved to a typical pseudokinase in some vertebrates, it retained the catalytic triad in humans. However, we show that putative catalysis by human BUBR1 is dispensable for error-free chromosome segregation. Instead, residues that interact with ATP in conventional kinases are essential for conformational stability in BUBR1. We propose that parallel evolution of BUBR1 orthologs rendered its kinase function dispensable in vertebrates, producing an unusual, triad-containing pseudokinase.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698286     DOI: 10.1016/j.devcel.2012.03.009

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  54 in total

1.  Protein evolution: keeping BUBR1 intact.

Authors:  Rachel David
Journal:  Nat Rev Mol Cell Biol       Date:  2012-07-11       Impact factor: 94.444

2.  Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human.

Authors:  Michael Schmid; Claus Steinlein; Qi Tian; Amy E Hanlon Newell; Manfred Gessler; Susan B Olson; Andreas Rosenwald; Burkhard Kneitz; Lev M Fedorov
Journal:  Chromosome Res       Date:  2014-07-01       Impact factor: 5.239

Review 3.  Making an effective switch at the kinetochore by phosphorylation and dephosphorylation.

Authors:  Hironori Funabiki; David J Wynne
Journal:  Chromosoma       Date:  2013-03-20       Impact factor: 4.316

4.  Drosophila Polo regulates the spindle assembly checkpoint through Mps1-dependent BubR1 phosphorylation.

Authors:  Carlos Conde; Mariana Osswald; João Barbosa; Tatiana Moutinho-Santos; Diana Pinheiro; Sofia Guimarães; Irina Matos; Helder Maiato; Claudio E Sunkel
Journal:  EMBO J       Date:  2013-05-17       Impact factor: 11.598

5.  Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling.

Authors:  Joo Seok Han; Benjamin Vitre; Daniele Fachinetti; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 6.  Understanding eukaryotic chromosome segregation from a comparative biology perspective.

Authors:  Snezhana Oliferenko
Journal:  J Cell Sci       Date:  2018-07-20       Impact factor: 5.285

7.  Mammalian myosin-18A, a highly divergent myosin.

Authors:  Stephanie Guzik-Lendrum; Sarah M Heissler; Neil Billington; Yasuharu Takagi; Yi Yang; Peter J Knight; Earl Homsher; James R Sellers
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 8.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 9.  Centromeres and kinetochores of Brassicaceae.

Authors:  Inna Lermontova; Michael Sandmann; Dmitri Demidov
Journal:  Chromosome Res       Date:  2014-06       Impact factor: 5.239

10.  Sensitivity to BUB1B Inhibition Defines an Alternative Classification of Glioblastoma.

Authors:  Eunjee Lee; Margaret Pain; Huaien Wang; Jacob A Herman; Chad M Toledo; Jennifer G DeLuca; Raymund L Yong; Patrick Paddison; Jun Zhu
Journal:  Cancer Res       Date:  2017-08-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.